Though several substrates of IGF2BP1 and IGF2BP3 are known in cancers, including ESCC, the downstream mRNAs regulated by IGF2BP2 are largely unknown. This evidence concerns the gene IGF2BP3 and esophageal squamous cell carcinoma.